Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 16 Genitourinary 9 Other hematologic neoplasm 6 Breast 5 Gynecologic 4 Lymphoid 2 Head & Neck 2 Thoracic 1 Plasma cell 1 Other 1 NET 1 Myeloid 1 Endocrine 1

Conditions

Neuroendocrine Tumors 394 Multiple Endocrine Neoplasia Type 1 156 Carcinoma, Neuroendocrine 123 Thyroid Cancer, Papillary 118 Pituitary Neoplasms 114 Thyroid Neoplasms 100 Pheochromocytoma 91 Neoplasms 79 Carcinoid Tumor 76 Thyroid Carcinoma, Anaplastic 73 Adrenocortical Carcinoma 73 Paraganglioma 65 Neoplasm Metastasis 56 Adenocarcinoma, Follicular 53 Carcinoma, Non-Small-Cell Lung 51 Carcinoma, Medullary 50 Insulinoma 49 Pancreatic Neoplasms 47 Adenoma, Islet Cell 47 Colorectal Neoplasms 44 Breast Neoplasms 44 Small Cell Lung Carcinoma 42 Sarcoma 42 Gastro-enteropancreatic neuroendocrine tumor 42 Carcinoma, Renal Cell 41 Somatostatinoma 38 Head and Neck Neoplasms 38 Melanoma 37 Lung Neoplasms 37 Adrenal Gland Neoplasms 34

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Frailty × Endocrine × Clear all

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡